Effect of the 2014 Clinical and Laboratory Standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospital.
Daniel B ChastainIjang NgandoChristopher M BlandCarlos Franco-ParedesW Anthony HawkinsPublished in: Annals of clinical microbiology and antimicrobials (2017)
Modification of breakpoints did not significantly impact susceptibility rates of cefazolin. Substituting cefazolin may decrease the overall drug cost by 77.5%. More data is needed to correlate in vitro findings with clinical outcomes using cefazolin for UTIs.